Only a decent catalyst will turn around the dreadful sentiment infecting the MYX share price.
The crazy Elizabeth Warren proposal for the US government to manufacture generics will never happen. If you read some of the comments on the Washington Post website you will agree with me. The WP is pretty left of centre but the majority of the posts were dead against the crazy Warren proposal.
The three catalysts, that individually, change MYX sentiment are:
Good H1 and H2 results for FY'19
FDA approval of NuvaRing
End of the DOJ generics cartel pricing case against MYX.
Nothing else matters.
Management are doing a great job, with the tiniest of mistakes in not including an outlook forecast in the AGM presentation. For mine it was a dumb mistake rather than anything sinister.
The fact that Scott Richards bought $6million of MYX shares is of great comfort to me. No CEO buys that many shares unless he absolutely believes he is on a winner.
Forget the conspiracy theories and concentrate on understanding those 3 potential catalysts.
GLTAH
MYX Price at posting:
80.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)